Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2012
Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage IIFrancesca Toffalorio, Davide Radice, Lorenzo Spaggiari, et al.
Cancer|September 17, 2025
Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinomaFabio Conforti, Laura Pala, Chiara Catania, et al.
Cancer Cell|March 11, 2025
Sex hormones, the anticancer immune response, and therapeutic opportunitiesFabio Conforti, Laura Pala, Diletta Di Mitri, et al.
Critical Reviews in Oncology/Hematology|August 26, 2023
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION groupChiara Catania, Andrea Riccardo Filippi, Claudia Sangalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future ResearchFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Breast (Edinburgh, Scotland)|March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trialsLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Oncotarget|April 18, 2018
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancerFrancesca Toffalorio, Mariacarmela Santarpia, Davide Radice, et al.
Seminars in Oncology|March 26, 2023
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysisLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Critical Reviews in Oncology/Hematology|July 23, 2013
Breast phyllodes tumor: a review of literature and a single center retrospective series analysisGianluca Spitaleri, Antonio Toesca, Edoardo Botteri, et al.
The Oncologist|March 29, 2014
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targetsFrancesca Toffalorio, Gianluca Spitaleri, Chiara Catania, et al.
Pageof 8